• SENSEX
    NIFTY 50
Business

COVID-19 treatment: Gilead signs licensing agreement for remdesivir with Cipla, Jubilant Life, Mylan, two others

Updated : May 13, 2020 12:52 AM IST

Remdesivir is an investigational broad spectrum anti-viral developed by Gilead and is being studied as a potential therapy for COVID-19.
COVID-19 treatment: Gilead signs licensing agreement for remdesivir with Cipla, Jubilant Life, Mylan, two others

You May Also Like

Live TV
Advertisement